Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Mesoblast Ltd (MSB AU)
Watchlist
42
Analysis
Health Care
•
Australia
Mesoblast Limited provides biomedical services. The Company develops drugs for cardiovascular diseases, oncology, hematology, and spine orthopedic disorders treatment. Mesoblast conducts its business worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Centuria Capital
•
05 Jul 2021 12:51
ASX200 Sep21 Index Rebalance Preview: Large Impact Names
We see 3 potential changes to the ASX200 at the Sep rebalance with CNI, PNI and SLK being included and NXL, NRW and GEM being deleted. Passive...
Brian Freitas
Follow
402 Views
Share
bullish
•
Allkem Ltd
•
28 May 2021 05:50
ASX200 Index Rebalance Preview: Gold Miners Shining
We see 3 potential changes to the ASX200 in the June review. All inclusions/exclusions have over 3 days of ADV to trade from passive funds. Short...
Brian Freitas
Follow
306 Views
Share
bullish
•
Codan
•
01 Mar 2021 06:18
ASX200 Index Rebalance Preview: Three Potential Changes & Some Close Names
We see three potential changes to the ASX200 in the March review while there are another two close adds/deletes. High short interest on the...
Brian Freitas
Follow
407 Views
Share
bullish
•
Mesoblast Ltd
•
01 Jul 2020 19:34
•
Issuer-paid
Mesoblast - COVID-19 ARDS Phase III readout later this year
Mesoblast has initiated a 300-patient randomized, controlled Phase III trial of remestemcel-L (Ryoncil for the acute graft versus host disease...
Edison Investment Research
Follow
80 Views
Share
bullish
•
Centuria Industrial REIT
•
12 Jun 2020 11:25
ASX200 Index Review - A Handful of Changes
S&P Dow Jones Indices announced changes to the S&P/ASX 200 (AS51 INDEX) today. The changes are effective at the open of trading on 22 June...
Brian Freitas
Follow
447 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.32.0
x